Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
A two arm study (1 Active, 1 Active control) to compare the incidence, progression and severity of chronic renal allograft failure in at-risk patients who are converted from cyclosporine-based to tacrolimus-based immunosuppression to patients who remain on cyclosporine-based therapy
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient has been on cyclosporine-based immunosuppression regimen since the transplant
Patient has at least one pre-defined risk factor for chronic allograft failure
You may not be if
Patient is dialysis dependent
Patient is recipient of a solid organ transplant other than the kidney